Professor Andrew Hyland

Prof Andrew Hyland has been a leader in tobacco control research for 30 years, conducting numerous peer-review funded grants and contracts that are informing policy and practice. He has more than 400 peer review papers, previously served as the Deputy Editor for the leading journal in the field, Tobacco Control, and he is widely recognized nationally and internationally for his expertise.

As the Chair of the Department of Health Behavior at Roswell Park Comprehensive Cancer Center, he directs a research program focused on providing an evidence base to inform interventions to reduce the disease burden caused by tobacco by as much and as quickly to as many people as possible. He serves as the Scientific Principal Investigator of the Population Assessment of Tobacco and Health (PATH) study, which is supported by the National Institute on Drug Abuse and the Food and Drug Administration to study longitudinally more than 46,000 adults and children nationally over a 14-year period to understand changes in tobacco use behaviors and health to inform FDA tobacco regulatory considerations. Prof Hyland is a Principal Investigator of the International Tobacco Control Policy Evaluation P01 grant that evaluates the impact of national and sub-national tobacco control policies on behavior. He also serves as the Principal Investigator of the New York State Quitline, which helps more than 30,000 tobacco users with the efforts to stop using tobacco each year. Prof Hyland has taken on other important policy relevant topics in tobacco control research, including identifying strategies to boost the reach and efficacy of stop smoking intervention, assessing the effectiveness of mass media anti-smoking campaigns, evaluating the impact of changes in product design and packaging, and surveillance of tobacco use, the tobacco-affiliated businesses, and other tobacco-related issues.

Institutional webpage: https://www.roswellpark.org/andrew-hyland